Korean J Anesthesiol Search

CLOSE


Korean Journal of Anesthesiology 2006;51(5):519-527.
DOI: https://doi.org/10.4097/kjae.2006.51.5.519   
New Inotropic Agent-Levosimendan.
In Cheol Choi
Department of Anesthesiology and Pain Medicine, University of Ulsan College of Medicine, Seoul, Korea. icchoi@amc.seoul.kr
Abstract
Several clinical studies suggest substantial limitations of currently available positive inotropic substances, including beta1-adrenoceptor agonists and phosphodiesterase III inhibitors. Levosimendan, a myofilament calcium sensitizer with inotropic effects, increases myocardial performance without substantial changes in oxygen consumption and with neutral effects on heart rhythm. In addition, levosimendan has vasodilatory effects that are achieved by stimulation of adenosine triphosphate-dependent potassium channels. This review article briefly discusses the pharmacology of levosimendan and evaluates current available evidence to assess the safety and efficacy of levosimendan.
Key Words: calcium sensitizer; inotropic; levosimendan


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
101-3503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-792-5128    Fax: +82-2-792-4089    E-mail: journal@anesthesia.or.kr                

Copyright © 2024 by Korean Society of Anesthesiologists.

Developed in M2PI

Close layer
prev next